Boston Scientific

DC BeadEmbolic Drug-Eluting Beads

SHARE

DC Bead is an embolic Drug-Eluting Bead capable of loading and releasing in a controlled manner chemotherapeutic agents. DC Bead is used in trans-arterial chemoembolisation (TACE). This is a minimally invasive (non-surgical) procedure performed by an interventional radiologist.

Most popular related searches

DC Bead is used in transarterial chemoembolisation (TACE). This is a minimally invasive (non-surgical) procedure performed by an interventional radiologist.

DC Bead is an embolic Drug-Eluting Bead capable of loading and releasing chemotherapeutic agents in a controlled manner.

DC Bead is produced from a biocompatible polyvinyl alcohol (PVA) hydrogel that has been modified with sulphonate groups for the controlled loading and delivery of chemotherapeutic drugs. DC Bead occludes the blood flow to the target tissue and delivers a local and sustained dose of drug direct to the tumour.

DC Bead is tinted blue for easy visualisation and is supplied in colour coded vials for added procedural safety and efficiency.

Drug-Eluting Bead: DEBDOX
DC Bead is intended to be loaded with doxorubicin for the purpose of:

  • Embolisation of vessels supplying malignant hypervascularised tumour(s)
  • Delivery of a local, controlled, sustained dose of doxorubicin to the tumour(s)

Drug-Eluting Bead: DEBIRI
DC Bead is intended to be loaded with irinotecan for the purpose of:

  • Embolisation of vessels supplying malignant colorectal cancer metastasised to the liver (mCRC)
  • Capable of eluting a local, controlled, sustained dose of irinotecan to hepatic metastases of colorectal cancer

DC Bead is CE-Mark approved for loading with doxorubicin (DEBDOX) and irinotecan (DEBIRI).